Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
| 87.65 | |
| 86.15 | |
| - | |
| 88 | |
| 85.68 | |
| 53-88 | |
| 17 826 M | |
| 0 | |
| 0 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
As global markets exhibit mixed signals with modest gains in some regions and cautious consumer behavior in others, investors are keenly observing market trends for potential opportunities. In such a ...
As global markets exhibit varied performance with the S&P 500 reaching new heights and sectors like manufacturing showing robust growth, investors may find opportunities in stocks that seem undervalue...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
